Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 382

1.

Comparison of antimicrobial stewardship programs in acute care hospitals in four European countries: a cross-sectional survey.

Kallen MC, Binda F, Ten Oever J, Tebano G, Pulcini C, Murri R, Beovic B, Saje A, Prins JM, Hulscher MEJL, Schouten JA; ESGAP (ESCMID Study Group for Antimicrobial stewardshiP).

Int J Antimicrob Agents. 2019 Jun 11. pii: S0924-8579(19)30146-3. doi: 10.1016/j.ijantimicag.2019.06.005. [Epub ahead of print]

PMID:
31200022
2.

Fever and a rapidly progressive skin ulcer after a visit to Morocco: A diagnostic challenge.

Anas AA, Prins JM, Bode N, de Vries HJC, Middeldorp S, Grobusch MP.

Travel Med Infect Dis. 2019 May 31. pii: S1477-8939(19)30097-3. doi: 10.1016/j.tmaid.2019.05.015. [Epub ahead of print] No abstract available.

PMID:
31158504
3.

The Accuracy of Anal Swab-Based Tests to Detect High-Grade Anal Intraepithelial Neoplasia in HIV-Infected Patients: A Systematic Review and Meta-analysis.

Dias Gonçalves Lima F, Viset JD, Leeflang MMG, Limpens J, Prins JM, de Vries HJC.

Open Forum Infect Dis. 2019 Apr 16;6(5):ofz191. doi: 10.1093/ofid/ofz191. eCollection 2019 May.

4.

OPTimal IMAging strategy in patients suspected of non-traumatic pulmonary disease at the emergency department: chest X-ray or ultra-low-dose CT (OPTIMACT)-a randomised controlled trial chest X-ray or ultra-low-dose CT at the ED: design and rationale.

van den Berk IAH, Kanglie MMNP, van Engelen TSR, Bipat S, Dijkgraaf MGW, Bossuyt PMM, de Monyé W, Prins JM, Stoker J.

Diagn Progn Res. 2018 Aug 8;2:20. doi: 10.1186/s41512-018-0038-1. eCollection 2018.

5.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group.

Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2.

6.

β-Lactam Allergy in the Operating Theater: Reply.

Hermanides J, Lemkes BA, Prins JM, Hollmann MW, Terreehorst I.

Anesthesiology. 2019 May;130(5):855-856. doi: 10.1097/ALN.0000000000002690. No abstract available.

PMID:
30994562
7.

Population Pharmacokinetics with Monte Carlo Simulations of Gentamicin in a Population of Severely Ill Adult Patients from Sub-Saharan Africa.

Bos JC, Prins JM, Mistício MC, Nunguiane G, Lang CN, Beirão JC, Mathôt RAA, van Hest RM.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02328-18. doi: 10.1128/AAC.02328-18. Print 2019 Apr.

PMID:
30917981
8.

Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial.

Finch AP, van Velzen P, Ter Riet G, Sterk PJ, Prins JM, Bosmans JE.

Pharmacoeconomics. 2019 May;37(5):689-699. doi: 10.1007/s40273-018-0756-9.

PMID:
30565022
9.

Testosterone Insufficiency in Human Immunodeficiency Virus-Infected Women: A Cross-Sectional Study.

Laan ETM, Prins JM, van Lunsen RHW, Nieuwkerk PT, Nievaard-Boon MAF.

Sex Med. 2019 Mar;7(1):72-79. doi: 10.1016/j.esxm.2018.10.002. Epub 2018 Dec 3.

10.

Development of actionable quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units: A modified-RAND Delphi study.

Kallen MC, Roos-Blom MJ, Dongelmans DA, Schouten JA, Gude WT, de Jonge E, Prins JM, de Keizer NF.

PLoS One. 2018 Nov 29;13(11):e0207991. doi: 10.1371/journal.pone.0207991. eCollection 2018.

11.

How to measure quantitative antibiotic use in order to support antimicrobial stewardship in acute care hospitals: a retrospective observational study.

Kallen MC, Natsch S, Opmeer BC, Hulscher MEJL, Schouten JA, Prins JM, van der Linden P.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):347-355. doi: 10.1007/s10096-018-3434-0. Epub 2018 Nov 26.

PMID:
30478815
12.

Patterns of Co-occurring Comorbidities in People Living With HIV.

De Francesco D, Verboeket SO, Underwood J, Bagkeris E, Wit FW, Mallon PWG, Winston A, Reiss P, Sabin CA; Pharmacokinetic and Clinical Observations in PeoPle Over fiftY (POPPY) study and the AGEhIV Cohort Study.

Open Forum Infect Dis. 2018 Oct 24;5(11):ofy272. doi: 10.1093/ofid/ofy272. eCollection 2018 Nov.

13.

The Skin Microbiota in Patients Hospitalized for Cellulitis and Association With Outcome.

Cranendonk DR, Hugenholtz F, Prins JM, Savelkoul PHM, Budding AE, Wiersinga WJ; DANCE Consortium .

Clin Infect Dis. 2019 Apr 8;68(8):1292-1299. doi: 10.1093/cid/ciy709.

PMID:
30321312
14.

A survey on antimicrobial stewardship prerequisites, objectives and improvement strategies: systematic development and nationwide assessment in Dutch acute care hospitals.

Kallen MC, Ten Oever J, Prins JM, Kullberg BJ, Schouten JA, Hulscher MEJL.

J Antimicrob Chemother. 2018 Dec 1;73(12):3496-3504. doi: 10.1093/jac/dky367.

PMID:
30252063
15.

Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation.

Wijnen BFM, Oberjé EJM, Evers SMAA, Prins JM, Nobel HE, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, van Hulzen AGW, van Broekhuizen M, de Bruin M.

Clin Infect Dis. 2019 Feb 1;68(4):658-667. doi: 10.1093/cid/ciy553.

PMID:
30239629
16.

Virological and Serological Predictors of Anal High-grade Squamous Intraepithelial Lesions Among Human Immunodeficiency Virus-positive Men Who Have Sex With Men.

Marra E, Siegenbeek van Heukelom ML, Leeman A, Waterboer T, Meijer CJLM, Snijders PJF, King AJ, Cairo I, van Eeden A, Brokking W, van der Weele P, Quint W, Prins JM, de Vries HJC, Schim van der Loeff MF.

Clin Infect Dis. 2019 Apr 8;68(8):1377-1387. doi: 10.1093/cid/ciy719.

PMID:
30165551
17.

Host Cell Deoxyribonucleic Acid Methylation Markers for the Detection of High-grade Anal Intraepithelial Neoplasia and Anal Cancer.

van der Zee RP, Richel O, van Noesel CJM, Novianti PW, Ciocanea-Teodorescu I, van Splunter AP, Duin S, van den Berk GEL, Meijer CJLM, Quint WGV, de Vries HJC, Prins JM, Steenbergen RDM.

Clin Infect Dis. 2019 Mar 19;68(7):1110-1117. doi: 10.1093/cid/ciy601.

18.

Human resources required for antimicrobial stewardship teams: a Dutch consensus report.

Ten Oever J, Harmsen M, Schouten J, Ouwens M, van der Linden PD, Verduin CM, Kullberg BJ, Prins JM, Hulscher MEJL; SWAB Working Group on Antimicrobial Stewardship.

Clin Microbiol Infect. 2018 Dec;24(12):1273-1279. doi: 10.1016/j.cmi.2018.07.005. Epub 2018 Jul 20.

PMID:
30036665
19.

Detection Rate of High-Grade Squamous Intraepithelial Lesions as a Quality Assurance Metric for High-Resolution Anoscopy in HIV-Positive Men.

Siegenbeek van Heukelom ML, Marra E, Cairo I, Van Eeden A, Schim van der Loeff MF, De Vries HJC, Prins JM.

Dis Colon Rectum. 2018 Jul;61(7):780-786. doi: 10.1097/DCR.0000000000001039.

PMID:
29771801
20.

Presumed β-Lactam Allergy and Cross-reactivity in the Operating Theater: A Practical Approach.

Hermanides J, Lemkes BA, Prins JM, Hollmann MW, Terreehorst I.

Anesthesiology. 2018 Aug;129(2):335-342. doi: 10.1097/ALN.0000000000002252. Review. No abstract available.

PMID:
29762180
21.

A clinical decision support system algorithm for intravenous to oral antibiotic switch therapy: validity, clinical relevance and usefulness in a three-step evaluation study.

Akhloufi H, Hulscher M, van der Hoeven CP, Prins JM, van der Sijs H, Melles DC, Verbon A.

J Antimicrob Chemother. 2018 Aug 1;73(8):2201-2206. doi: 10.1093/jac/dky141.

PMID:
29718336
22.

Preventive Antibiotics in Stroke Study (PASS): A cost-effectiveness study.

Westendorp WF, Zock E, Vermeij JD, Kerkhoff H, Nederkoorn PJ, Dijkgraaf MGW, van de Beek D; PASS investigators.

Neurology. 2018 May 1;90(18):e1553-e1560. doi: 10.1212/WNL.0000000000005412. Epub 2018 Apr 6.

PMID:
29626176
23.

Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.

Rottier WC, van Werkhoven CH, Bamberg YRP, Dorigo-Zetsma JW, van de Garde EM, van Hees BC, Kluytmans JAJW, Kuck EM, van der Linden PD, Prins JM, Thijsen SFT, Verbon A, Vlaminckx BJM, Ammerlaan HSM, Bonten MJM.

Clin Microbiol Infect. 2018 Dec;24(12):1315-1321. doi: 10.1016/j.cmi.2018.03.023. Epub 2018 Mar 23.

PMID:
29581056
24.

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.

Vlot MC, Grijsen ML, Prins JM, de Jongh RT, de Jonge R, den Heijer M, Heijboer AC.

PLoS One. 2018 Mar 9;13(3):e0193679. doi: 10.1371/journal.pone.0193679. eCollection 2018.

25.

Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study.

Bos JC, Prins JM, Mistício MC, Nunguiane G, Lang CN, Beirão JC, Mathôt RAA, van Hest RM.

J Antimicrob Chemother. 2018 Jun 1;73(6):1620-1629. doi: 10.1093/jac/dky071.

PMID:
29522167
26.

Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study.

Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.

J Int AIDS Soc. 2018 Mar;21(3). doi: 10.1002/jia2.25083.

27.

Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).

Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, Schouten JA, Degener JE, van de Garde EMW, Verheij TJ, Sachs APE, Prins JM.

Neth J Med. 2018 Jan;76(1):4-13.

28.

The antibiotic checklist: an observational study of the discrepancy between reported and actually performed checklist items.

van Daalen FV, Hulscher MEJL, Minderhoud C, Prins JM, Geerlings SE.

BMC Infect Dis. 2018 Jan 8;18(1):16. doi: 10.1186/s12879-017-2878-7.

29.

Wild-type HIV infection despite PrEP: a lot to learn from a case report - Authors' reply.

Hoornenborg E, Prins M, Prins JM, de Bree GJ.

Lancet HIV. 2018 Jan;5(1):e10-e11. doi: 10.1016/S2352-3018(17)30214-X. No abstract available.

PMID:
29290224
30.

Cellulitis: current insights into pathophysiology and clinical management.

Cranendonk DR, Lavrijsen APM, Prins JM, Wiersinga WJ.

Neth J Med. 2017 Nov;75(9):366-378. Review.

31.

Non-targeted HIV screening in emergency departments in the Netherlands.

Luiken GPM, Joore IK, Taselaar A, Schuit SCE, Geerlings SE, Govers A, Rood PPM, Prins JM, Nichols BE, Verbon A, de Vries-Sluijs TEMS.

Neth J Med. 2017 Nov;75(9):386-393.

32.

Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study.

Bos JC, Mistício MC, Nunguiane G, Mathôt RAA, van Hest RM, Prins JM.

BMC Res Notes. 2017 Dec 4;10(1):671. doi: 10.1186/s13104-017-3016-8.

33.

Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.

Smolders EJ, Smit C, de Kanter C, Dofferhoff A, Arends JE, Brinkman K, Rijnders B, van der Valk M, Reiss P, Burger DM; ATHENA National HIV Observational Cohort.

HIV Med. 2018 Mar;19(3):216-226. doi: 10.1111/hiv.12570. Epub 2017 Dec 1.

PMID:
29194939
34.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands.

Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, Rijnders BJA, Brinkman K, van der Valk M; NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort .

Clin Infect Dis. 2018 Apr 17;66(9):1352-1359. doi: 10.1093/cid/cix1004.

PMID:
29186365
35.

Pharmacokinetics and Pharmacodynamic Target Attainment of Benzylpenicillin in an Adult Severely Ill Sub-Saharan African Patient Population.

Bos JC, van Hest RM, Mistício MC, Nunguiane G, Lang CN, Beirão JC, Mathôt RAA, Prins JM.

Clin Infect Dis. 2018 Apr 3;66(8):1261-1269. doi: 10.1093/cid/cix961.

PMID:
29112711
36.

Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?

Siegenbeek van Heukelom ML, Marra E, de Vries HJC, Schim van der Loeff MF, Prins JM.

AIDS. 2017 Oct 23;31(16):2295-2301. doi: 10.1097/QAD.0000000000001639.

37.

The economic evaluation of an antibiotic checklist as antimicrobial stewardship intervention.

van Daalen FV, Opmeer BC, Prins JM, Geerlings SE, Hulscher MEJL.

J Antimicrob Chemother. 2017 Nov 1;72(11):3213-3221. doi: 10.1093/jac/dkx259.

PMID:
28981722
38.

Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.

Hoornenborg E, Prins M, Achterbergh RCA, Woittiez LR, Cornelissen M, Jurriaans S, Kootstra NA, Anderson PL, Reiss P, de Vries HJC, Prins JM, de Bree GJ; Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam Consortium (H-TEAM).

Lancet HIV. 2017 Nov;4(11):e522-e528. doi: 10.1016/S2352-3018(17)30132-7. Epub 2017 Sep 14.

PMID:
28919303
39.

HIV testing week 2015: lowering barriers for HIV testing among high-risk groups in Amsterdam.

Bartelsman M, Joore IK, van Bergen JE, Hogewoning AA, Zuure FR, van Veen MG; HIV Transmission Elimination AMsterdam (H-TEAM) initiative.

BMC Infect Dis. 2017 Aug 1;17(1):529. doi: 10.1186/s12879-017-2617-0.

40.

Antibiotic stewardship: does it work in hospital practice? A review of the evidence base.

Hulscher MEJL, Prins JM.

Clin Microbiol Infect. 2017 Nov;23(11):799-805. doi: 10.1016/j.cmi.2017.07.017. Epub 2017 Jul 24. Review.

41.

Pharmacokinetics of Antibiotics in Sub-Saharan African Patient Populations: A Systematic Review.

Bos JC, van Hest RM, Prins JM.

Ther Drug Monit. 2017 Aug;39(4):387-398. doi: 10.1097/FTD.0000000000000418. Review.

PMID:
28703719
42.

Cryotherapy for Intra- and Perianal High-Grade Squamous Intraepithelial Lesions in HIV-Positive Men who have Sex with Men.

Siegenbeek van Heukelom ML, Gosens KCM, Prins JM, de Vries HJC.

Am J Clin Dermatol. 2018 Feb;19(1):127-132. doi: 10.1007/s40257-017-0311-z.

43.

[Mapping HIV prevalence in the Netherlands with geographic information systems].

Op de Coul ELM, Joore IK, van Sighem A, Bom BCJ, Hillebregt M, Prins JM, Geerlings SE, van Bergen JEAM.

Ned Tijdschr Geneeskd. 2017;161:D965. Dutch.

PMID:
28677511
44.

Clinical condition and comorbidity as determinants for blood culture positivity in patients with skin and soft-tissue infections.

van Daalen FV, Kallen MC, van den Bosch CMA, Hulscher MEJL, Geerlings SE, Prins JM.

Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1853-1858. doi: 10.1007/s10096-017-3001-0. Epub 2017 Jun 7.

45.

Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.

van Velzen P, Ter Riet G, Bresser P, Baars JJ, van den Berg BTJ, van den Berg JWK, Brinkman P, Dagelet JWF, Daniels JMA, Groeneveld-Tjiong DRGL, Jonkers RE, van Kan C, Krouwels FH, Pool K, Rudolphus A, Sterk PJ, Prins JM.

Lancet Respir Med. 2017 Jun;5(6):492-499. doi: 10.1016/S2213-2600(17)30165-0. Epub 2017 May 5.

PMID:
28483402
46.

A Systematic Review of Quality Indicators for Appropriate Antibiotic Use in Hospitalized Adult Patients.

Kallen MC, Prins JM.

Infect Dis Rep. 2017 Mar 30;9(1):6821. doi: 10.4081/idr.2017.6821. eCollection 2017 Mar 30. Review.

47.

Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital.

Deelen JWT, Visser CE, Prins JM, van Hest RM.

BMC Infect Dis. 2017 Apr 21;17(1):296. doi: 10.1186/s12879-017-2354-4.

48.

Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients.

van Bilsen WPH, van den Berg CHSB, Rijnders BJA, Brinkman K, Mulder JW, Gelinck LBS, Hoepelman AIM, Wit FWNM, van de Beek D, Prins JM.

AIDS. 2017 Jun 19;31(10):1415-1424. doi: 10.1097/QAD.0000000000001492.

PMID:
28375874
49.

Longitudinal dynamics of the HIV-specific B cell response during intermittent treatment of primary HIV infection.

de Bree GJ, Wheatley AK, Lynch RM, Prabhakaran M, Grijsen ML, Prins JM, Schmidt SD, Koup RA, Mascola JR, McDermott AB.

PLoS One. 2017 Mar 15;12(3):e0173577. doi: 10.1371/journal.pone.0173577. eCollection 2017.

50.

Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial.

de Bruin M, Oberjé EJM, Viechtbauer W, Nobel HE, Hiligsmann M, van Nieuwkoop C, Veenstra J, Pijnappel FJ, Kroon FP, van Zonneveld L, Groeneveld PHP, van Broekhuizen M, Evers SMAA, Prins JM.

Lancet Infect Dis. 2017 Jun;17(6):595-604. doi: 10.1016/S1473-3099(16)30534-5. Epub 2017 Mar 3.

PMID:
28262598

Supplemental Content

Loading ...
Support Center